Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P.

Blood. 2006 May 1;107(9):3772-8.

2.

Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.

Uy GL, Rettig MP, Cashen AF.

Expert Opin Biol Ther. 2008 Nov;8(11):1797-804. doi: 10.1517/14712598.8.11.1797 . Review.

PMID:
18847313
3.

Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.

Flomenberg N, DiPersio J, Calandra G.

Acta Haematol. 2005;114(4):198-205. Review.

PMID:
16269859
4.

In and out of the niche: perspectives in mobilization of hematopoietic stem cells.

Mohty M, Ho AD.

Exp Hematol. 2011 Jul;39(7):723-9. doi: 10.1016/j.exphem.2011.05.004. Review.

PMID:
21624427
5.

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.

Pusic I, DiPersio JF.

Curr Opin Hematol. 2010 Jul;17(4):319-26. doi: 10.1097/MOH.0b013e328338b7d5. Review.

PMID:
20473162
8.

Can every patient be mobilized?

DiPersio JF.

Best Pract Res Clin Haematol. 2010 Dec;23(4):519-23. doi: 10.1016/j.beha.2010.09.011. Review.

PMID:
21130416
9.

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

De Clercq E.

Biochem Pharmacol. 2009 Jun 1;77(11):1655-64. doi: 10.1016/j.bcp.2008.12.014. Review.

PMID:
19161986
10.

The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .

Haas R, Murea S.

Cytokines Mol Ther. 1995 Dec;1(4):249-70. Review. Erratum in: Cytokines Mol Ther 1996 Mar;2(1):136.

PMID:
9384679
11.

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Cashen AF, Lazarus HM, Devine SM.

Bone Marrow Transplant. 2007 May;39(10):577-88. Review.

PMID:
17369869
12.

Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobilâ„¢) and potential of other CXCR4 antagonists as stem cell mobilizers.

De Clercq E.

Pharmacol Ther. 2010 Dec;128(3):509-18. doi: 10.1016/j.pharmthera.2010.08.009. Review.

PMID:
20826182
13.

Optimizing stem cell collection through CXCR4 antagonists.

Mahaseth H, Kaufman J.

Front Biosci (Schol Ed). 2012 Jan 1;4:611-9. Review.

PMID:
22202080
14.

Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Pelus LM, Fukuda S.

Leukemia. 2008 Mar;22(3):466-73. Review.

15.

Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Pelus LM.

Curr Opin Hematol. 2008 Jul;15(4):285-92. doi: 10.1097/MOH.0b013e328302f43a. Review.

17.

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Rettig MP, Ansstas G, DiPersio JF.

Leukemia. 2012 Jan;26(1):34-53. doi: 10.1038/leu.2011.197. Review.

18.

Plerixafor for stem cell mobilization: the current status.

Bilgin YM, de Greef GE.

Curr Opin Hematol. 2016 Jan;23(1):67-71. doi: 10.1097/MOH.0000000000000200. Review.

PMID:
26554889
19.

New strategies for mobilization of hematopoietic stem cells.

Fruehauf S, Seeger T.

Future Oncol. 2005 Jun;1(3):375-83. Review.

PMID:
16556011
20.

Advances in stem cell mobilization.

Hopman RK, DiPersio JF.

Blood Rev. 2014 Jan;28(1):31-40. doi: 10.1016/j.blre.2014.01.001. Review.

Items per page

Supplemental Content

Support Center